These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3459061)

  • 1. Does theophylline improve dyspnea in nonreversible COPD?
    Cohen BM
    N J Med; 1986 Apr; 83(4):227-31. PubMed ID: 3459061
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.
    Mahler DA; Matthay RA; Snyder PE; Wells CK; Loke J
    Am Rev Respir Dis; 1985 Jan; 131(1):22-5. PubMed ID: 3966709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of theophylline in the treatment of dyspnea in COPD.
    Mahler DA
    Chest; 1987 Jul; 92(1 Suppl):2S-6S. PubMed ID: 3297522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effectiveness of bamifylline in elderly patients with COPD].
    Cogo R; Monzani GP; Fusillo M; Vota M
    Minerva Med; 1991 Mar; 82(3):115-8. PubMed ID: 2006029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspnea in the patient with chronic obstructive pulmonary disease. Etiology and management.
    Sweer L; Zwillich CW
    Clin Chest Med; 1990 Sep; 11(3):417-45. PubMed ID: 1976053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
    Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
    Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic errors in dyspnea].
    Entzian P; Barth J
    Z Arztl Fortbild (Jena); 1993 Apr; 87(5):417-24. PubMed ID: 8391737
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dyspnea in obstructive and restrictive pulmonary processes].
    Ratto OR; Santos ML; Bogossian M; Afonso JE; Jardim JR
    Arq Bras Cardiol; 1973 Feb; 26(1):39-48. PubMed ID: 4731934
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
    Oren R; Beeri M; Hubert A; Kramer MR; Matzner Y
    Arch Intern Med; 1997 Jul; 157(13):1474-8. PubMed ID: 9224226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.
    Gilbert R
    Am Rev Respir Dis; 1985 Jul; 132(1):195. PubMed ID: 4014867
    [No Abstract]   [Full Text] [Related]  

  • 11. [A bronchodilator and spasmolytic of a new formula: AC 3810 (trentadil). Clinical trial and comparison with theophylline].
    de Lostalot J
    J Med Bord; 1967 Apr; 144(4):596-602. PubMed ID: 5611089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dyspnea grade as a prognostic factor in patients with chronic obstructive pulmonary disease].
    Aida A; Miyamoto K; Nakano T; Yamamoto M; Nishimura M; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):9-16. PubMed ID: 8114379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline therapy in obstructive respiratory diseases. 2. Theophyllin-retard preparations for the long-term treatment of non-smokers with or without cardiac insufficiency (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):42-6. PubMed ID: 6782562
    [No Abstract]   [Full Text] [Related]  

  • 14. [Symptomatic pharmacological treatment of dyspnea].
    Fitting JW
    Rev Mal Respir; 1993; 10(2):165-70. PubMed ID: 8502798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Theophylline, myocardial infarction and hypertrophic obstructive cardiomyopathy].
    Harry P; Jobard S; Merheb M; Tran P
    Therapie; 1998; 53(6):606-8. PubMed ID: 10070246
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
    Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI
    Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyspnea crisis experienced by couples in their home].
    Gagné L; Pepin J; Michaud C
    Infirm Que; 2000; 7(6):20-30. PubMed ID: 11022462
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating dyspnea in a patient with advanced chronic obstructive pulmonary disease.
    Runo JR; Ely EW
    West J Med; 2001 Sep; 175(3):197-201. PubMed ID: 11527853
    [No Abstract]   [Full Text] [Related]  

  • 20. [Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):36-41. PubMed ID: 7208408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.